Ocean Biomedical Overview
Latest ROE for Ocean Biomedical: 26.56% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow26.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, OCEA shows a ROE of 26.56%. That is above the sector sector average of -4.03%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about -4.03%. Ocean Biomedical is at 26.56%, which is higher that average. That is roughly 759.8% above the sector mean. Use the comparison chart on this page to see how OCEA stacks up against individual peers as well.
Check the historical chart to see whether OCEA's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ocean Biomedical with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Ocean Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 26.56%) with ownership activity and broader fundamentals.
